Annual Total Expenses
$723.80 M
-$23.61 M-3.16%
December 31, 2023
Summary
- As of February 7, 2025, VIR annual total expenses is $723.80 million, with the most recent change of -$23.61 million (-3.16%) on December 31, 2023.
- During the last 3 years, VIR annual total expenses has risen by +$359.57 million (+98.72%).
- VIR annual total expenses is now -3.16% below its all-time high of $747.40 million, reached on December 31, 2022.
Performance
VIR Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$218.88 M
+$85.58 M+64.21%
September 30, 2024
Summary
- As of February 7, 2025, VIR quarterly total expenses is $218.88 million, with the most recent change of +$85.58 million (+64.21%) on September 30, 2024.
- Over the past year, VIR quarterly total expenses has increased by +$85.58 million (+64.21%).
- VIR quarterly total expenses is now -8.03% below its all-time high of $238.00 million, reached on December 31, 2021.
Performance
VIR Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
VIR Total Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -3.2% | +64.2% |
3 y3 years | +98.7% | +15.2% |
5 y5 years | +505.4% | +15.2% |
VIR Total Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -3.2% | +8.6% | -8.0% | +66.7% |
5 y | 5-year | -3.2% | +305.1% | -8.0% | +241.3% |
alltime | all time | -3.2% | +786.5% | -8.0% | +716.7% |
Vir Biotechnology Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $218.88 M(+64.2%) |
Jun 2024 | - | $133.30 M(+1.5%) |
Mar 2024 | - | $131.28 M(-16.6%) |
Dec 2023 | $723.80 M(-3.2%) | $157.36 M(-12.2%) |
Sep 2023 | - | $179.26 M(-9.0%) |
Jun 2023 | - | $197.10 M(+3.7%) |
Mar 2023 | - | $190.08 M(+10.3%) |
Dec 2022 | $747.40 M(+12.2%) | $172.29 M(-2.4%) |
Sep 2022 | - | $176.47 M(-3.3%) |
Jun 2022 | - | $182.53 M(-15.5%) |
Mar 2022 | - | $216.11 M(-9.2%) |
Dec 2021 | $666.32 M | $238.00 M(+52.5%) |
Sep 2021 | - | $156.10 M(+38.2%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2021 | - | $112.97 M(-29.1%) |
Mar 2021 | - | $159.24 M(+46.5%) |
Dec 2020 | $364.23 M(+103.8%) | $108.70 M(+23.8%) |
Sep 2020 | - | $87.80 M(-7.9%) |
Jun 2020 | - | $95.32 M(+31.7%) |
Mar 2020 | - | $72.40 M(+12.9%) |
Dec 2019 | $178.69 M(+49.5%) | $64.13 M(+33.8%) |
Sep 2019 | - | $47.92 M(+33.6%) |
Jun 2019 | - | $35.85 M(+16.5%) |
Mar 2019 | - | $30.79 M(+14.9%) |
Dec 2018 | $119.56 M(+46.4%) | $26.80 M(-22.2%) |
Sep 2018 | - | $34.46 M |
Dec 2017 | $81.65 M | - |
FAQ
- What is Vir Biotechnology annual total expenses?
- What is the all time high annual total expenses for Vir Biotechnology?
- What is Vir Biotechnology annual total expenses year-on-year change?
- What is Vir Biotechnology quarterly total expenses?
- What is the all time high quarterly total expenses for Vir Biotechnology?
- What is Vir Biotechnology quarterly total expenses year-on-year change?
What is Vir Biotechnology annual total expenses?
The current annual total expenses of VIR is $723.80 M
What is the all time high annual total expenses for Vir Biotechnology?
Vir Biotechnology all-time high annual total expenses is $747.40 M
What is Vir Biotechnology annual total expenses year-on-year change?
Over the past year, VIR annual total expenses has changed by -$23.61 M (-3.16%)
What is Vir Biotechnology quarterly total expenses?
The current quarterly total expenses of VIR is $218.88 M
What is the all time high quarterly total expenses for Vir Biotechnology?
Vir Biotechnology all-time high quarterly total expenses is $238.00 M
What is Vir Biotechnology quarterly total expenses year-on-year change?
Over the past year, VIR quarterly total expenses has changed by +$85.58 M (+64.21%)